2024 annual financial data
Protara Therapeutics 2024 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -49.15M USD and net income was -44.6M USD.
Operating cash flow was -35.81M USD.
Get free Protara Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -49.15M USD
- Net income
- -44.6M USD
- Operating cash flow
- -35.81M USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Protara Therapeutics financial years